Review article

THE ROLE OF CITICOLINE IN OCULAR NEURODEGENERATIVE DISEASES

Melita Adilović-Čabrić orcid.org/0000-0003-3059-6848 ; Polyclic with Day Hospital Doboj jug, Trg 21. Mart, 74 203, Matuzići, Bosnia and Herzegovina; Special clinic for eye dieases „Royal ophthalmology“, Karađorđeva 18, 74 000 Doboj, Bosnia and Herzegovina *
Nejra Hodžić ; General and Special hospital Plava (Blue) Medical Group, 3. Tuzlanske brigade 7, 75 000, Tuzla, Bosnia and Herzegovina

* Corresponding author.

Abstract

Ocular neurodegenerative diseases such as glaucoma, diabetic retinopathy and age-related macular degeneration are the most common retinal diseases causing visual impairment and blindness in the working age elderly population in developed countries. Conventional therapy is either used in an advanced stage of the disease or is not sufficient on its own. Therefore, new treatment modalities are sought, especially in the earlier stages of the disease, in order to prevent disease progression before visual acuity is impaired, and patient's quality of life is altered. Neuroprotection is increasingly popular term used not only to describe the pathology of the central nervous system, but also eye diseases. One of the proposed neuroprotectors of the eye is citicoline. This review provides comprehensive data on the use of citicoline in the most common ocular neurodegenerative diseases.

Keywords

neurodegeneration; neuroprotection; citicoline; eye; brain

Hrčak ID:

342914

URI

https://hrcak.srce.hr/342914

Publication date:

31.12.2025.

Visits: 787 *